General Information of the Compound
| Compound ID |
CP0913106
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-(2'-(imidazolylacetamido)morphinan
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H30N4O4
|
||||||||||||||||||
| Molecular Weight |
450.539
|
||||||||||||||||||
| Canonical SMILES |
O=C(Cc1ncc[nH]1)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H30N4O4/c30-17-4-3-15-11-18-25(32)6-5-16(28-20(31)12-19-26-8-9-27-19)23-24(25,21(15)22(17)33-23)7-10-29(18)13-14-1-2-14/h3-4,8-9,14,16,18,23,30,32H,1-2,5-7,10-13H2,(H,26,27)(H,28,31)/t16-,18-,23+,24+,25-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NHRHCPPWGBUABG-OIUZVZFJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02264, Kappa-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor